Fortress Biotech, Inc. (FBIOP) Depreciation & Amortization (CF) (2011 - 2026)

Fortress Biotech's Depreciation & Amortization (CF) history runs 14 years deep, the most recent figure standing at $103000.0 for Q4 2025.

• In Q4 2025, Depreciation & Amortization (CF) fell 26.43% year-over-year to $103000.0; the TTM figure through Dec 2025 stood at $429000.0 (down 57.82% YoY), while the FY2025 annual figure was $403000.0, down 61.25% from the prior year.
• Depreciation & Amortization (CF) for Q4 2025 stood at $103000.0, up from $100000.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $844000.0 in Q1 2023, with the low at $100000.0 in Q3 2024.
• The 5-year median for Depreciation & Amortization (CF) is $500000.0 (2021), against an average of $476250.0.
• The sharpest annual moves came in 2022 and 2024: Depreciation & Amortization (CF) soared 33.33% in 2022, then plunged 75.0% in 2024.
• Fortress Biotech's Depreciation & Amortization (CF) stood at $732000.0 in 2021, then gained by 9.29% to $800000.0 in 2022, then slumped by 62.5% to $300000.0 in 2023, then sank by 53.33% to $140000.0 in 2024, then decreased by 26.43% to $103000.0 in 2025.
• Business Quant data shows FBIOP's Depreciation & Amortization (CF) at $103000.0 in Q4 2025, $100000.0 in Q3 2025, and $100000.0 in Q2 2025.